These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro. Johnson VA; Merrill DP; Chou TC; Hirsch MS J Infect Dis; 1992 Nov; 166(5):1143-6. PubMed ID: 1328402 [TBL] [Abstract][Full Text] [Related]
32. Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds. Malley SD; Grange JM; Hamedi-Sangsari F; Vila JR Lancet; 1994 May; 343(8908):1292. PubMed ID: 7910296 [No Abstract] [Full Text] [Related]
33. Resistance, drug failure, and disease progression. Richman DD AIDS Res Hum Retroviruses; 1994 Aug; 10(8):901-5. PubMed ID: 7811540 [TBL] [Abstract][Full Text] [Related]
34. When the unthinkable happens: post-exposure prophylaxis of HIV-contaminated percutaneous injuries. Petty TL J Can Dent Assoc; 1999 May; 65(5):293-4. PubMed ID: 10380407 [No Abstract] [Full Text] [Related]
35. Therapy for human immunodeficiency virus infection -- what have we learned? Corey L; Holmes KK N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046 [No Abstract] [Full Text] [Related]
36. Most common prescribing error in postexposure prophylaxis of HIV/AIDS. Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343 [No Abstract] [Full Text] [Related]
37. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Beltrami EM; Luo CC; de la Torre N; Cardo DM Infect Control Hosp Epidemiol; 2002 Jun; 23(6):345-8. PubMed ID: 12083242 [TBL] [Abstract][Full Text] [Related]
38. 3TC/AZT: just another combination. GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997 [TBL] [Abstract][Full Text] [Related]
39. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults. Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851 [TBL] [Abstract][Full Text] [Related]
40. [Combination therapies with anti-retroviral agents in HIV and AIDS infections]. Fernández-Cruz E Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]